223 Preclinical assessment of nintedanib for chemoprevention in hepatocellular carcinoma

Victoria Tovar; Agrin Moeini; Sara Torrecilla; Mónica Higuera; Judit Peix; I.M. Quetglas; Leonardo Rodríguez‐Carunchio; Helena Cornellà; M Solé; Josep M. Llovet

doi:10.1016/s0959-8049(14)70349-1

Related publications

Article2015

P0224 : Nintedanib prevents the development of hepatocellular carcinoma in a mouse model of fibrosis

Victoria Tovar, A. Moeni, Sara Torrecilla, Mónica Higuera, Judit Peix, I.M. Quetglas, Leonardo Rodríguez‐Carunchio, Manel Solé, Josep M. Llovet

Journal of Hepatology

Article2021

Immunotherapies for hepatocellular carcinoma

Josep M. Llovet, Florian Castet, Mathias Heikenwälder, Mala K. Maini, Vincenzo Mazzaferro, David J. Pinato, Eli Pikarsky, Andrew X. Zhu, Richard S. Finn

Nature Reviews Clinical Oncology

Article2025

THU-077-YI E7386 enhances lenvatinib’s antitumor efficacy and upregulates ATF4 signalling in preclinical models and human hepatocellular carcinoma

Agavni Mesropian, Albert Gris‐Oliver, Ugne Balaseviciute, Martí Torres-Marcen, Jordi Abril‐Fornaguera, Marta Piqué‐Gili, David Camell, Judit Peix, Elisa Fernández-Martínez, Júlia Huguet‐Pradell, Ieva Keraite, Roger Esteban-Fabró, Takayuki Kimura, Alka A. Potdar, Marina Bárcena‐Varela, Katherine E. Lindblad, Amaia Lujambio, Ernesto Guccione, Swan N. Thung, Daniela Sia, Roser Pinyol, Josep M. Llovet

Article2006

Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma?

R. Vilana, Luís Bianchi, Marı́a Varela, Carlos Nicolau, Marcelo Sánchez, Carmen Ayuso, Montserrat García, María Sala, Josep M. Llovet, Jordi Bruix, Brú C

European Radiology

Article2021

Hepatocellular carcinoma

Josep M. Llovet, Robin Kate Kelley, Augusto Villanueva, Amit G. Singal, Eli Pikarsky, Sasan Roayaie, Riccardo Lencioni, Kazuhiko Koike, Jessica Zucman‐Rossi, Richard S. Finn

Nature Reviews Disease Primers